Winningham Rick E 4
4 · Theravance Biopharma, Inc. · Filed Nov 22, 2024
Insider Transaction Report
Form 4
Winningham Rick E
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Tax Payment
Ordinary Shares
2024-11-20$9.97/sh−15,997$159,490→ 1,811,095 total
Holdings
- 3,900(indirect: As Custodian)
Ordinary Shares
- 92,567(indirect: By Trust)
Ordinary Shares
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.